(S,Z)-N-(1-bromo-1-(3-bromophenyl)-3-((1-hydroxy-3-phenylpropan-2-yl)amino)-3-oxoprop-1-en-2-yl)benzamide

ID: ALA4757555

PubChem CID: 162656175

Max Phase: Preclinical

Molecular Formula: C25H22Br2N2O3

Molecular Weight: 558.27

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccccc1)=C(/Br)c1cccc(Br)c1

Standard InChI:  InChI=1S/C25H22Br2N2O3/c26-20-13-7-12-19(15-20)22(27)23(29-24(31)18-10-5-2-6-11-18)25(32)28-21(16-30)14-17-8-3-1-4-9-17/h1-13,15,21,30H,14,16H2,(H,28,32)(H,29,31)/b23-22-/t21-/m0/s1

Standard InChI Key:  XGOXPWALRLWCNO-MUBPVYAGSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   26.7760   -1.1597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7749   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4829   -2.3882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1926   -1.9788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1898   -1.1561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4812   -0.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4827   -3.2054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7749   -3.6138    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   28.1903   -3.6142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1902   -4.4314    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8982   -3.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6058   -3.6145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8984   -2.3886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.3136   -3.2061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0212   -3.6149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3138   -2.3889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0216   -1.9805    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0210   -4.4321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8978   -4.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8976   -5.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6056   -4.4317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.1907   -6.0635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1902   -6.8799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8983   -7.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6085   -6.8767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6055   -6.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3136   -4.8362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3130   -5.6527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0212   -6.0622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7313   -5.6494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7284   -4.8344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0682   -0.7513    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 14 12  1  6
 14 15  1  0
 14 16  1  0
 16 17  1  0
 15 18  1  0
 10 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 20  1  0
 18 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 18  1  0
  1 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757555

    ---

Associated Targets(Human)

HepG2 2.2.15 (869 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 558.27Molecular Weight (Monoisotopic): 555.9997AlogP: 4.66#Rotatable Bonds: 8
Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.10CX Basic pKa: CX LogP: 4.54CX LogD: 4.54
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.35Np Likeness Score: -0.56

References

1. Gu X,Zhang Y,Zou Y,Li X,Guan M,Zhou Q,Qiu J.  (2021)  Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.,  29  [PMID:33285406] [10.1016/j.bmc.2020.115892]

Source